Skip to main content
Year archive

Abliva — 2021 filings

All 40 regulatory filings released by Abliva (ABLI) in 2021, sourced directly from the official regulator.

40 Filings
2021 Period
2021 filings (40)
Filing Released Lang
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-12-27 English
Kallelse till extra bolagsstämma i Abliva AB (publ)
AGM Information
2021-12-21 Swedish
Notice of Extraordinary General Meeting of Abliva AB (publ)
AGM Information
2021-12-21 English
Abliva resolves on directed issue of convertibles amounting to SEK 26 million
Share Issue/Capital Change
2021-12-20 English
Abliva beslutar om riktad emission av konvertibler om sammanlagt 26 miljoner SEK
Share Issue/Capital Change
2021-12-20 Swedish
Abliva’s IND for clinical development of KL1333 approved by FDA
Regulatory Filings
2021-11-24 English
Ablivas IND för klinisk utveckling av KL1333 godkänd av FDA
Regulatory Filings
2021-11-24 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report 9M 2021
2021-11-19 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report 9M 2021
2021-11-19 English
Interim / Quarterly Report 2021
Interim / Quarterly Report H1 2021
2021-08-19 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report H1 2021
2021-08-19 English
Amended number of shares and votes in Abliva AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2021-05-31 English
Ändring av antal aktier och röster i Abliva AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2021-05-31 Swedish
Beslut vid årsstämma i Abliva AB (publ)
AGM Information
2021-05-20 Swedish
Resolutions from Annual General Meeting in Abliva AB (publ)
AGM Information
2021-05-20 English
Interim / Quarterly Report 2021
Interim / Quarterly Report Q1 2021
2021-05-20 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Q1 2021
2021-05-20 English
Abliva rapporterar positiva resultat för KL1333 i klinisk fas 1a/b-studie, inklusive tecken på effekt hos PMD-patienter
Earnings Release FY 2021
2021-05-19 Swedish
Abliva reports positive clinical Phase 1a/b results for KL1333 including signs of efficacy in PMD patients
Earnings Release FY 2021
2021-05-19 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-05-03 English
Abliva offentliggör prospekt och ny information som återfinns i prospektet
Capital/Financing Update
2021-04-30 Swedish
Abliva publishes prospectus and new information contained in the prospectus
Capital/Financing Update
2021-04-30 English
Amended number of shares and votes in Abliva AB (publ)
Share Issue/Capital Change
2021-04-30 English
Ändring av antal aktier och röster i Abliva AB (publ)
Share Issue/Capital Change
2021-04-30 Swedish
Beslut vid extra bolagsstämma i Abliva AB (publ)
AGM Information
2021-04-29 Swedish
Resolutions at the Extraordinary General Meeting in Abliva AB (publ)
Share Issue/Capital Change
2021-04-29 English
Annual Report 2020
Annual Report FY 2020
2021-04-27 Swedish
Annual Report 2020
Annual Report FY 2020
2021-04-27 English
Notice of Annual General Meeting of Abliva AB (publ)
AGM Information
2021-04-19 English
Kallelse till årsstämma i Abliva AB (publ)
AGM Information
2021-04-19 Swedish
Kallelse till extra bolagsstämma i Abliva AB (publ)
AGM Information
2021-03-31 Swedish
Notice of Extraordinary General Meeting of Abliva AB (publ)
AGM Information
2021-03-31 English
Abliva har genomfört en riktad nyemission
Share Issue/Capital Change
2021-03-30 Swedish
Abliva has completed a directed new issue
Share Issue/Capital Change
2021-03-30 English
Abliva utreder förutsättningarna för att genomföra riktad nyemission
Capital/Financing Update
2021-03-30 Swedish
Abliva investigates the prerequisites for carrying out a directed new issue
Capital/Financing Update
2021-03-30 English
Interim / Quarterly Report 2020
Interim / Quarterly Report FY 2020
2021-02-19 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report FY 2020
2021-02-19 English
Abliva utser Ellen Donnelly som ny VD inför en ny fas i bolagets utveckling
Board/Management Information
2021-01-20 Swedish
Abliva appoints Ellen Donnelly as new CEO as it enters a new stage in its development
Board/Management Information
2021-01-20 English